4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001628280-26-003147
Chief Financial Officer sold 15,213 shares at $4.03 ($61,308)
- Chief Financial Officer acquired 44,363 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelly John Alexander Chief Financial Officer | 2026-01-20 | Option exercise 10b5-1 | +3,888 | 81,186 | D | ||
| Kelly John Alexander Chief Financial Officer | 2026-01-20 | Option exercise 10b5-1 | +13,900 | 95,086 | D | ||
| Kelly John Alexander Chief Financial Officer | 2026-01-20 | Option exercise 10b5-1 | +26,575 | 121,661 | D | ||
| Kelly John Alexander Chief Financial Officer | 2026-01-21 | Sale 10b5-1 | −15,213 | $4.03 | $61,308 | 106,448 | D |
| Derivatives | |||||||
| Kelly John Alexander Chief Financial Officer | 2026-01-20 | Option exercise · Restricted Stock Units 10b5-1 | −3,888 | 0 | D | ||
| Kelly John Alexander Chief Financial Officer | 2026-01-20 | Option exercise · Restricted Stock Units 10b5-1 | −13,900 | 13,901 | D | ||
| Kelly John Alexander Chief Financial Officer | 2026-01-20 | Option exercise · Restricted Stock Units 10b5-1 | −26,575 | 26,575 | D | ||
| Open-market sales · 15,213 sh · avg $4.03 · $61,308 | |||||||
Loading xslF345X05/wk-form4_1769125714.xml…